Join us at the 10th Plasma Product Biotechnology conference, at the Radisson Blu Resort.
Learn about our latest developments to overcome IgG purification and regulatory bottlenecks.
Immunoglobulin (IgG) is known to be the driver of the plasma industry and manufacturers are facing increasing pressures to provide safe, efficacious and secure supply of these therapeutics.
In addition, the switch to subcutaneous administration as well as increasing regulatory requirements on isoagglutinin have led to major improvements in patients’ lives.
The presentations will describe our latest innovations in the production of subcutaneous IgG formulations and the removal of isoagglutinin. We look forward to seeing you.
Our Presentations
Tuesday, May 16 - 12:00 - 12:30
High Viscosity Tangential Flow Filtration (TFF) Applications in IgG
Craig Jackson et al, EMD Millipore Corporation, Bedford, MA, USA
Thursday, May 18 - 16:00 - 16:30
Eshmuno® P Anti-A and Anti-B: Affinity Resins for Removal of Anti-A and Anti-B Isoagglutinin
Santosh B. Rahane et al, EMD Millipore Corporation, Bedford, MA, USA
Plasma Resources
Blood Plasma Fractionation
We can help you better serve your patients globally, in specific therapeutic areas of the plasma fractionation process.
Venue Information
Radisson Blu Resort
St. George’s Bay
STJ3391 St Julians, Malta